Characterization of potential degradation products of brexpiprazole by liquid chromatography/quadrupole–time‐of‐flight mass spectrometry and nuclear magnetic resonance, and prediction of their physicochemical properties by ADMET Predictor™-Reference-Cited by-同舟云学术

Characterization of potential degradation products of brexpiprazole by liquid chromatography/quadrupole–time‐of‐flight mass spectrometry and nuclear magnetic resonance, and prediction of their physicochemical properties by ADMET Predictor™

Published:2022-11-09 Issue:1 Volume:37 Page:
ISSN:0951-4198
Container-title:Rapid Communications in Mass Spectrometry
language:en
Short-container-title:Rapid Comm Mass Spectrometry

Author:

Kushwah Bhoopendra Singh¹,Singh Saranjit²,Thummar Mohit M.³,Balhara Ankit²,Samanthula Gananadhamu¹^ORCID

Affiliation:

1. Department of Pharmaceutical Analysis National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad Telangana India

2. Department of Pharmaceutical Analysis National Institute of Pharmaceutical Education and Research (NIPER) SAS Nagar Punjab India

3. Zydus Cadila Healthcare Limited Ahmedabad Gujarat India

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rcm.9415

Reference28 articles.

1. Adjunctive brexpiprazole for the treatment of major depressive disorder

2. Brexpiprazole: A review of a new treatment option for schizophrenia and major depressive disorder

3. “Ghost Peak” Driven Structural Elucidation of a Photocatalytic Degradation Product from Brexpiprazole

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification, characterization, and in silico ADMET prediction of nirmatrelvir and its degradation products using HPLC‐PDA and LC‐QTOF‐MS/MS;Rapid Communications in Mass Spectrometry;2024-08-26

2. LC-HRMS and NMR studies for the characterization of degradation impurities of ubrogepant along with the in silico approaches for the prediction of degradation and toxicity;Journal of Pharmaceutical and Biomedical Analysis;2024-06